Grover’s-like drug eruption in a patient with metastatic melanoma under ipilimumab therapy

BACKGROUND: Dermatologic toxicity is an important adverse effect of immune checkpoint inhibitors targeting cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) and programmed cell death 1 receptor (PD-1) or PD ligand 1 (PD-L1). Skin toxicity most commonly includes a maculopapular erythematous rash a...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Immunother Cancer
Main Authors: Koelzer, Viktor H., Buser, Tobias, Willi, Niels, Rothschild, Sacha I., Wicki, Andreas, Schiller, Peter, Cathomas, Gieri, Zippelius, Alfred, Mertz, Kirsten D.
格式: Artigo
語言:Inglês
出版: BioMed Central 2016
主題:
Case Report
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4986338/
https://ncbi.nlm.nih.gov/pubmed/27532022
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-016-0151-z
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍